Hypocalcemia


Etiology

Pseudohypocalcemia

  • Interference with Colorimetric Laboratory Calcium Assay
    • Gadodiamide MRI Angiography Contrast: in addition, since the contrast is excreted renally, it may be retained for prolonged periods after the MRI
    • Gadoversetamide MRI Angiography Contrast: in addition, since the contrast is excreted renally, it may be retained for prolonged periods after the MRI

Hypoparathyroidism (Low Parathyroid Hormone)

Genetic

  • Abnormal Parathyroid Gland Development
    • DiGeorge Syndrome
    • Mutations in the Transcription Factor Glial-Cell Missing B (GCMB)
  • Abnormal Parathyroid Hormone Synthesis
  • Activating Mutations of Calcium-Sensing Receptor (CaSR)
    • Autosomal Dominant Hypocalcemia
    • Sporadic Isolated Hypoparathyroidism

Autoimmune

  • Polyglandular Autoimmune Syndrome Type I
    • Epidemiology
      • Associated with Chronic Mucocutaneous Candidiasis and Primary Adrenal Insufficiency
  • Isolated Hypoparathyroidism Due to Activating Antibodies to Calcium-Sensing Receptor (CaSR)

Postoperative

  • General Comments
    • Surgical Etiologies are the Most Common Causes of Hypoparathyroidism
  • Parathyroidectomy (see Parathyroidectomy)
  • Radical Neck Dissection (for Head and Neck Cancer)
  • Thyroidectomy (see Thyroidectomy)

Infiltration of Parathyroid Gland

  • Granulomatous Infiltration of Parathyroid Gland
  • Hemochromatosis (see Hemochromatosis)
  • Metastases to Parathyroid Gland
  • Wilson Disease (see Wilson Disease)
    • XXXXX

Other

  • Radiation-Induced Destruction of Parathyroid Gland
  • Human Immunodeficiency Virus (HIV) (see Human Immunodeficiency Virus)
  • Hungry Bone Syndrome (Post-Parathyroidectomy)

Secondary Hyperparathyroidism in Response to Hypocalcemia (High Parathyroid Hormone)

Vitamin D Deficiency/Resistance (see Vitamin D)

  • Etiology
    • Nutritional Vitamin D Deficiency and Decreased Cutaneous Vitamin D Synthesis
    • Vitamin D Deficiency Due to Abnormal Synthesis and Catabolism
      • Chronic Kidney Disease (CKD)
        • Low Calcitriol (1,25 Dihydroxyvitamin D) Production Due to Decreased Glomerular Filtration Rate, Loss of the 1-Alpha-Hydroxylase Enzyme Secondary to Structural Renal Disease, and Suppression of Enzyme Activity Due to Hyperphosphatemia and Resultant Increased Circulating FGF23 Levels
      • Drugs (Inducers of P-450 Enzyme, Which Metabolizes Calcidiol to Inactive Vitamin D Metabolites)
      • Cirrhosis/Liver Disease (see Cirrhosis)
      • Nephrotic Syndrome (see Nephrotic Syndrome)
        • Due to Loss of Calcidiol (25-Hydroxyvitamin D) Bound to Vitamin D-Binding Protein
      • Vitamin D-Dependent Rickets Type I
    • Vitamin D Resistance
      • Hereditary Vitamin D-Resistant Rickets (HVDRR)
  • Physiology
    • Decreased Synthesis or Action of Vitamin D, Resulting in Hypocalcemia with a High Parathyroid Hormone (PTH) Level

Parathyroid Hormone Resistance

  • Hypomagnesemia (see Hypomagnesemia)
    • Epidemiology
      • Interestingly, a Few Patients with Magnesium-Responsive Hypocalcemia But Normal Serum Magnesium Levels Have Also Been Reported
    • Physiology
      • Hypomagnesemia Can Decrease Parathyroid Hormone (PTH) Secretion or Cause Parathyroid Hormone (PTH) Resistance
      • Parathyroid Hormone (PTH) Resistance Occurs When Serum Magnesium Concentration Falls to <0.8 mEq/L (<1 mg/dL or <0.4 mmol/L)
    • Diagnosis
      • Associated with Low/Normal/High Parathyroid Hormone Levels
      • Most Patients Have Low-Normal Serum Phosphate Levels (Likely Due to Poor Phosphate Intake)
  • Missense Mutation in Parathyroid Hormone
  • Pseudohypoparathyroidism

Renal Disease

  • Acute Kidney Injury (AKI) (see Acute Kidney Injury)
  • Chronic Kidney Disease (CKD) (see Chronic Kidney Disease)
    • Epidemiology
      • Hypocalcemia Does Not Occur Until the GFR Falls to <15 mL/min
    • Physiology
      • Decrease in Renal Production of 1,25-Dihydroxyvitamin D
      • Hyperphosphatemia Also Contributes to Development of Hypocalcemia

Loss of Calcium from Circulation

  • Acute Pancreatitis (see Acute Pancreatitis)
    • Epidemiology
      • XXXX
    • Physiology
      • Saponification of Calcium Soaps within the Inflamed Pancreas and Abdominal Cavity
  • Acute Respiratory Alkalosis (see Respiratory Alkalosis)
    • Physiology
      • XXXXX
  • Acute Severe Illness
    • Epidemiology
      • Hypocalcemia is Common in Critical Ill Patients (Occurs in Up to 80-90% of Cases)
    • Physiology
      • Impaired Parathyroid Hormone (PTH) Secretion
      • Decreased Calcitriol Production
      • End-Organ Parathyroid Hormone (PTH) Resistance
  • Hyperphosphatemia (see Hyperphosphatemia)
    • Epidemiology
      • Acute Hyperphosphatemia, Resulting from Increased Phosphate Intake (Phosphate Enemas, Oral Phosphate Replacement) in the Setting of Renal Failure, Can Result in Acute Hypocalcemia
      • Chronic Hyperphosphatemia is Usually Due to Decreased Phosphate Clearance in Chronic Kidney Disease
        • In These Cases, Primary Impairment of Calcitriol Synthesis (Resulting in Decreased Intestinal Calcium Absorption) Further Exacerbates the Hypocalcemia
    • Physiology
      • Hyperphosphatemia Results in Calcium Deposition, Mostly in Bone (But Also in Extraskeletal Tissues)
  • Osteoblastic Bone Metastases
    • Etiology
    • Physiology
      • Due to Deposition of Calcium in the Newly Formed Bone Around the Tumor
  • Rhabdomyolysis (see Rhabdomyolysis)
    • Epidemiology
      • Patients are Typically Hypocalcemic During the Oliguric Phase of Acute Kidney Injury (Due to Acute Tubular Necrosis)
    • Physiology
      • In Setting of Decreased Renal Excretion of Phosphate, Hyperphosphatemia from Tissue Breakdown Results in Calcium Deposition, Mostly in Bone (But Also in Extraskeletal Tissues)
  • Sepsis (see Sepsis)
    • Epidemiology
      • Hypocalcemia is Common in Critical Illness (Approaching 80-90% of Cases)
    • Commonly Associated Etiologies
    • Physiology
      • Impaired Parathyroid Hormone (PTH) Secretion
      • Decreased Calcitriol Production
      • End-Organ Parathyroid Hormone (PTH) Resistance
  • Severe Burns (see Burns)
  • Tumor Lysis Syndrome (see Tumor Lysis Syndrome)
    • Physiology
      • In the Setting of Decreased Renal Excretion of Phosphate, Hyperphosphatemia from Tumor Breakdown Results in Calcium Deposition, Mostly in Bone (But Also in Extraskeletal Tissues)

Drugs/Toxins

Inhibitors of Bone Resorption

  • Bisphosphonates (see Bisphosphonates)
    • Epidemiology
      • Hypocalcemia is More Frequently Seen When Potent Bisphosphonates (Such as Zoledronate) are Used and in Patients with Underlying Vitamin D Deficiency, Unrecognized Hypoparathyroidism, or Chronic Kidney Disease
    • Pharmacology
      • Bisphosphonates Reduce Osteoclastic Bone Resorption
  • Calcitonin (see Calcitonin)
    • Pharmacology
  • Denosumab (Xgeva, Prolia) (see Denosumab)
    • Pharmacology
      • Denosumab is a Fully Human Monoclonal Antibody to the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL), Which is an Osteoclast Differentiating Factor

Other Drugs/Toxins

  • 5-Fluorouracil (5-FU) and Leucovorin (see 5-Fluorouracil)
    • Epidemiology
      • Hypocalcemia Occurred in 65% of Cases (in One Series of Patients)
    • Physiology
      • Probably Due to a Decrease in Calcitriol Production
  • Calcium Chelators
    • Ethylenediaminetetraacetic Acid (EDTA) (see Ethylenediaminetetraacetic Acid)
    • Citrate (see Citrate)
      • Massive Blood Product Transfusion (see Packed Red Blood Cells): due to citrate binding of calcium
        • Diagnosis: in cases due to large-volume blood product transfusion, total calcium is normal but ionized calcium is decreased
        • Clinical: hypocalcemia is usually transient and there is no evidence that the treatment of hypocalcemia in this setting is beneficial
      • Plasmapheresis (see Plasmapheresis): hypocalcemia is common during plasmapheresis
    • Phosphate
  • Cinacalcet (Sensipar) (see Cinacalcet)
    • Pharmacology
      • Cinacalcet is a Calcimimetic Drug
  • Fluoride Intoxication (see Fluoride)
    • Physiology
      • Formation of Fluorapatite
  • Foscarnet (Foscavir) (see Foscarnet)
    • Physiology
      • Due to Intravascular Complexing of Foscarnet with Calcium
  • Lenvatinib (Lenvima) (see Lenvatinib)
    • Physiology
      • Tyrosine Kinase Inhibitor Which Induces Hypocalcemia Via Parathyroid Hormone Dependent and Parathyroid Hormone-Independent Mechanisms (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • Phenytoin (Dilantin) (see Phenytoin)
    • Physiology
      • Due to Phenytoin-Induced Conversion of Vitamin D to Inactive Metabolites
  • Sorafenib (Nexavar) (see Sorafenib)
    • Physiology
      • Tyrosine Kinase Inhibitor (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • Vandetanib (Caprelsa) (see Vandetanib)
    • Physiology
      • Tyrosine Kinase Inhibitor Which Induces Hypocalcemia Via Parathyroid Hormone Dependent and Parathyroid Hormone-Independent Mechanisms (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • White Phosphorus Toxicity (see White Phosphorus)
    • Epidemiology
      • Associated with Systemic Toxicity
    • Clinical
      • Hypocalcemia in the Setting of White Phosphorus Toxicity May Be Severe

Other

  • Dengue (see Dengue Virus)
    • Epidemiology
      • Dengue Fever Has Been Associated with Hypocalcemia (Int J Crit Illn Inj Sci, 2014) [MEDLINE]
    • Physiology
      • Likely Multifactorial
    • Clinical
      • As Suggested in In Vitro Studies, Derangements of Calcium Homeostasis are Likely to Be Associated with Myocardial Dysfunction and Cardiac Arrhythmias in the Setting of Dengue Virus Infection
  • Ethylene Glycol Intoxication (see Ethylene Glycol)
    • Physiology
      • Due to Calcium Oxalate Formation
  • Hydrofluoric Acid Inhalation (see Hydrofluoric Acid)
  • Hypomagnesemia (see Hypomagnesemia)
    • Epidemiology
      • Interestingly, a Few Patients with Magnesium-Responsive Hypocalcemia But Normal Serum Magnesium Levels Have Also Been Reported
    • Physiology
      • Hypomagnesemia Can Decrease Parathyroid Hormone (PTH) Secretion or Cause Parathyroid Hormone (PTH) Resistance
      • Parathyroid Hormone (PTH) Resistance Occurs When Serum Magnesium <0.8 mEq/L (1 mg/dL or 0.4 mmol/L)
    • Diagnosis
      • Associated with Low/Normal/High Parathyroid Hormone (PTH) Levels
      • Most Patients Have Low-Normal Serum Phosphate Levels (Probably Due to Poor Phosphate Intake)
  • Post-Surgery
    • Epidemiology
      • Hypocalcemia May Occur Postoperatively Even in Cases Where No Blood Products Have Been Given
    • Physiology
      • Due to Volume Expansion and Hypoalbuminemia
    • Diagnosis
      • Ionized Calcium is Normal in Most of These Cases
  • Severe Hypermagnesemia (see Hypermagnesemia)
    • Epidemiology
      • During Aggressive Magnesium Therapy in Pre-Eclampsia
      • During Magnesium Replacement in the Setting of Aneurysmal Subarachnoid Hemorrhage (Neurocrit Care, 2008) [MEDLINE]
    • Physiology
      • Suppression of Parathyroid Hormone (PTH) Secretion
    • Diagnosis
      • Occurs with Serum Magnesium Concentration >5 mEq/L (>6 mg/dL or >2.5 mmol/L)


Clinical Manifestations

Acute Hypocalcemia

Cardiovascular Manifestations

  • Arrhythmias
    • Clinical
      • XXXX
  • Congestive Heart Failure (CHF) (see Congestive Heart Failure)
    • Epidemiology
      • Cases of Hypocalcemia-Associated Heart Failure Have Been Extensively Reported (Anesth Analg, 1976) [MEDLINE] (Am J Nephrol, 1990) [MEDLINE] (Am J Kidney Dis, 1994) [MEDLINE] (Clin Nephrol, 2006) [MEDLINE] (Am J Med Sci, 2007) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE]
  • Hypotension (see Hypotension)
    • Epidemiology
      • Cases of Hypocalcemia-Associated Hypotension Have Been Extensively Reported (Am J Kidney Dis, 1994) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE] (Hemodial Int, 2016) [MEDLINE]
      • Hypocalcemia-Associated Hypotension is Most Commonly Seen When it is Rapidly Induced by Ethylenediaminetetraacetic Acid (EDTA), Transfusion of Citrated Blood, Products, or with the Use of Low Calcium Dialysate in Patients Undergoing Dialysis
    • Physiology
      • XXXX
  • Prolonged Q-T with Increased Risk of Torsade (see Torsade)
    • Clinical
      • XXXX
  • Syncope (see Syncope)
    • Epidemiology
      • XXXX

Neurologic Manifestations

  • Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) (see Pseudotumor Cerebri)
  • Seizures (see Seizures)
  • Tetany (Neuromuscular Irritability) (see Tetany)
    • Epidemiology
      • Patients with a Gradual Decline in Serum Calcium Tend to Have Fewer Symptoms at the Same Calcium Level than Patients with Acute Hypocalcemia (Endocrinol Metab Clin North Am, 1993) [MEDLINE]
      • Tetany Usually Only Occurs when Ionized Calcium Falls to Below 1.1 mmol/L (Corresponding to a Total Serum Calcium of Approximately 7-7.5 mg/dL)
    • Physiology
      • Acute Hypocalcemia Increases Neuromuscular Irritability (Brain, 1991) [MEDLINE]: hyperexcitability occurs at central nervous system level, spinal reflex level, and motor endplate level
      • Hypocalcemia and Alkalosis Act Synergistically to Cause Tetany (see Metabolic Alkalosis] and Respiratory Alkalosis)
        • Respiratory Alkalosis Can Cause Tetany Even in the Absence of Hypocalcemia
    • Diagnosis
    • Clinical
      • General Comments
        • Tetany Manifests as Both Sensory and Motor Dysfunction (Endocrinol Metab Clin North Am, 1993) [MEDLINE]
      • Autonomic Manifestations
      • Chvostek’s Sign (see Chvostek’s Sign)
        • Tapping of the Facial Nerve Hust Anterior to the Ear Elicits Contraction of the Ipsilateral Facial Muscles
        • Sensitivity for Hypocalcemia: 29%
        • Chvostek’s Sign Occurs in Approximately 10% of Normal Subjects
      • Clumsiness
      • Hyperreflexia (see Hyperreflexia)
      • Laryngospasm (Laryngismus Stridulus) (see Laryngospasm) (J Emerg Med, 2015) [MEDLINE] (BMJ Case Rep, 2018) [MEDLINE] (Front Horm Res, 2019) [MEDLINE]
      • Muscle Cramps (see Muscle Cramps)
      • Muscle Spasms/Twitching
      • Myalgias (see Myalgias)
      • Perioral/Acral Paresthesias (see Paresthesias)
        • These Symptoms Can Cause Hyperventilation, Resulting in Respiratory Alkalosis, Which Exacerbates the Paresthesias
      • Stiffness
      • Trousseau’s Sign (see Trousseau Sign)
        • Other Name for Sign: “main d’accoucheur” (French for “hand of the obstetrician”) because it resembles the position of an obstetrician’s hand in delivering a baby
        • Inflated Blood Pressure Cuff for 3 min Elicits Carpopedal Spasm in the Hand/Forearm
        • Sensitivity for Hypocalcemia: 94%

Chronic Hypocalcemia

Neuropsychiatric

Other


Treatment

Oral Calcium Replacement

Intravenous Calcium Replacement

  • Clinical Efficacy
    • Systematic Review of Parenteral Calcium Replacement in Critical Care Patients (Cochrane Database Syst Rev, 2008) [MEDLINE]: no evidence that parenteral calcium replacement improves outcome in critically ill patients
  • Agents
    • Calcium Chloride (in 10 ml = 10%) (see Calcium Chloride): 1 amp over 30-60 min
    • Calcium Gluconate (see Calcium Gluconate): 1 amp IV over 30-60 min
      • Avoid Use in Liver Disease
  • Adverse Effects
    • Carpopedal Spasm: with rapid infusion


References

General

Clinical Manifestations

Laryngospasm (see Laryngospasm)

Other

Treatment